UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

Journal of clinical oncology, 2011-01, Vol.29 (2), p.200-207

2011

Volltextzugriff (PDF)

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies

Blood, 2012-04, Vol.119 (16), p.3668-3683

2012

Volltextzugriff (PDF)

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

Clinical cancer research, 2009-09, Vol.15 (17), p.5494-5502

2009

Volltextzugriff (PDF)

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Journal of clinical oncology, 2013-12, Vol.31 (36), p.4520-4528

2013

Volltextzugriff (PDF)

Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2008-10, Vol.26 (28), p.4587-4594

2008

Volltextzugriff (PDF)

Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B‐cell lymphoma

Neuropathology, 2017-12, Vol.37 (6), p.509-516

2017

Volltextzugriff (PDF)

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

The American journal of surgical pathology, 2015-10, Vol.39 (10), p.1322-1330

2015

Volltextzugriff (PDF)

Membrane-type 1 Matrix Metalloproteinase Regulates Macrophage-dependent Elastolytic Activity and Aneurysm Formation in Vivo

The Journal of biological chemistry, 2009-01, Vol.284 (3), p.1765-1771

2009

Volltextzugriff (PDF)

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

The New England journal of medicine, 2002-06, Vol.346 (25), p.1937-1947

2002

Volltextzugriff (PDF)

Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential

Frontiers in oncology, 2020-05, Vol.10, p.640-640

2020

Volltextzugriff (PDF)

Diagnosis of primary vitreoretinal lymphoma masquerading infectious retinitis by retinal biopsy

Journal of ophthalmic inflammation and infection, 2024-02, Vol.14 (1), p.8-8, Article 8

2024

Volltextzugriff (PDF)

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

Journal of hematology and oncology, 2023-12, Vol.16 (1), p.122-122, Article 122

2023

Volltextzugriff (PDF)

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

Blood, 2013-09, Vol.122 (13), p.2233-2241

2013

Volltextzugriff (PDF)

Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential

Insights into imaging, 2019-04, Vol.10 (1), p.46-14, Article 46

2019

Volltextzugriff (PDF)

Low-Dose Chemotherapy for Epstein-Barr Virus–Positive Post-Transplantation Lymphoproliferative Disease in Children After Solid Organ Transplantation

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6481-6488

2005

Volltextzugriff (PDF)

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Blood, 2019-04, Vol.133 (15), p.1664-1676

2019

Volltextzugriff (PDF)

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

Molecular cancer therapeutics, 2008-06, Vol.7 (6), p.1450-1460

2008

Volltextzugriff (PDF)

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

Modern pathology, 2005-10, Vol.18 (10), p.1377-1384

2005

Volltextzugriff (PDF)

Transitioning From T-Cell Clonality Testing to High-Throughput Sequencing

The Journal of molecular diagnostics : JMD, 2021-07, Vol.23 (7), p.781-783

2021

Volltextzugriff (PDF)

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

Blood, 2019-03, Vol.133 (12), p.1313-1324

2019

Volltextzugriff (PDF)

Rituximab Improves the Outcome of Patients with Grade 3 Follicular Lymphoma Receiving Anthracycline-based Therapy

Clinical lymphoma, myeloma and leukemia, 2017-08, Vol.17 (8), p.488-497.e2

2017

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

Englisch
(234)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(148)
Humans
(146)
Male
(77)
Female
(71)
Biological And Medical Sciences
(66)
Medical Sciences
(66)
Middle Aged
(66)
Hematology
(63)
Aged
(58)
Adult
(57)
Hematologic And Hematopoietic Diseases
(55)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(53)
Pathology
(51)
Prognosis
(50)
Oncology
(40)
Aged, 80 And Over
(33)
Lymphoma, Large B-Cell, Diffuse - Genetics
(33)
Gene Expression Profiling
(32)
Adolescent
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma

Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B‐cell lymphoma

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

Membrane-type 1 Matrix Metalloproteinase Regulates Macrophage-dependent Elastolytic Activity and Aneurysm Formation in Vivo

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential

Diagnosis of primary vitreoretinal lymphoma masquerading infectious retinitis by retinal biopsy

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential

Low-Dose Chemotherapy for Epstein-Barr Virus–Positive Post-Transplantation Lymphoproliferative Disease in Children After Solid Organ Transplantation

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

Transitioning From T-Cell Clonality Testing to High-Throughput Sequencing

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

Rituximab Improves the Outcome of Patients with Grade 3 Follicular Lymphoma Receiving Anthracycline-based Therapy

Suchergebnisse filtern